On the 19th, the immuno-oncology theme rose by 3.76% compared to the previous day, showing strong performance, while Abclon, a related stock drawing attention, surged by 5.24% compared to the previous day. Abclon is known as the only domestic bio new drug development specialist among listed companies.
[Graph] Price Fluctuations of Major Stocks in the Immuno-Oncology Theme
According to the analysis by Thinkpool Robo Algorithm RASSI, Abclon's quant financial score is 10.4 points, with higher growth and stability scores than the average of other stocks related to immuno-oncology, ranking 13th within the theme. This indicates that compared to other stocks in the theme, Abclon's revenue and net income growth rates are relatively fast, and its ability to respond to changes in domestic and international economic environments is also favorable.
[Table] Top Stocks by Financial Scores within the Theme
※ The quant financial score is the result of the robo algorithm's analysis based on each company's revenue growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, etc.
※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
